Hyperuricemia and Eye Disease: The Ocular Consequences of Elevated Uric Acid

David Stephen Klein, MD FACA FACPM
3 days ago
3 min read

Introduction

Uric acid is traditionally discussed in the context of gout and kidney stones. Yet mounting evidence suggests that hyperuricemia may exert significant effects on the microvasculature — including the delicate vascular networks of the eye.

The retina, optic nerve, and choroid are metabolically active tissues dependent upon precise vascular regulation.

When uric acid levels rise, oxidative stress, endothelial dysfunction, and inflammatory signaling may follow — with measurable ocular consequences.

Mechanistic Overview

Elevated serum uric acid can contribute to ocular pathology through several pathways:

Endothelial dysfunction
Increased oxidative stress
Nitric oxide depletion
Microvascular constriction
Inflammatory cytokine activation
Crystal deposition (rare but reported intraocularly)

These mechanisms mirror systemic cardiovascular effects, but within a far more fragile microvascular bed.

Infographic showing eye conditions linked to elevated uric acid, including retinal vein occlusion, diabetic retinopathy, and inflammatory ocular injury. — Hyperuricemia and Eye Disease Risk Infographic

Ocular Conditions Associated with Hyperuricemia

1. Glaucoma

Several observational studies demonstrate an association between elevated uric acid and increased intraocular pressure as well as primary open-angle glaucoma risk¹².

Mechanisms proposed include:

Microvascular optic nerve compromise
Endothelial dysfunction
Impaired autoregulation of ocular blood flow

2. Retinal Vascular Disease

Hyperuricemia correlates with:

Retinal vein occlusion
Hypertensive retinopathy
Diabetic retinopathy severity³

Uric acid may potentiate microvascular injury through pro-inflammatory and pro-thrombotic effects.

3. Age-Related Macular Degeneration (AMD)

Oxidative stress is central to macular degeneration. Elevated uric acid — paradoxically both antioxidant and pro-oxidant depending on context — may contribute to retinal pigment epithelium dysfunction⁴.

The relationship remains under active investigation but is biologically plausible.

4. Uveitis and Inflammatory Eye Disease

Systemic inflammatory states associated with metabolic syndrome and hyperuricemia may increase susceptibility to ocular inflammation.

Rare case reports describe urate crystal deposition in ocular tissues⁵.

Laboratory and Risk Assessment

When evaluating ocular vascular disease, it may be prudent to assess:

Serum uric acid
Renal function
Lipid profile
Fasting insulin / metabolic markers
Blood pressure

Hyperuricemia frequently coexists with metabolic syndrome — compounding vascular risk.

Clinical Implications

Hyperuricemia may serve as:

A biomarker of vascular stress
A contributor to microvascular compromise
A modifiable metabolic target

While causality continues to be studied, the association between elevated uric acid and ocular vascular disease is increasingly recognized.

In patients with:

Unexplained glaucoma progression
Recurrent retinal vascular events
Early macular degeneration
Metabolic syndrome

…uric acid assessment may be warranted.

Bottom Line

Uric acid is more than a gout marker. Medications to lower uric acid are available, inexpensive and very well tolerated.

Elevated levels may contribute to ocular microvascular dysfunction, glaucoma risk, retinal vascular disease, and inflammatory eye conditions.

Evaluating and managing hyperuricemia may represent an overlooked component of comprehensive ocular and cardiovascular risk reduction.

Become a Patient

If you have metabolic syndrome, recurrent retinal issues, unexplained glaucoma progression, or elevated uric acid levels, a comprehensive metabolic and vascular assessment may provide clarity.

🔹 Precision laboratory evaluation🔹 Cardiometabolic risk stratification🔹 Individualized management strategies

Become a Patient → stagesoflifemedicalinstitute.com

References

Li S, et al. Serum uric acid and primary open-angle glaucoma risk. Br J Ophthalmol. 2019.
Wang J, et al. Hyperuricemia and glaucoma association study. Sci Rep. 2017.
Hu Y, et al. Serum uric acid and retinal vascular disease. PLoS One. 2014.
Kowluru RA, et al. Oxidative stress in retinal disease. Exp Diabetes Res. 2012.
Reddy AK, et al. Ocular manifestations of gout. Surv Ophthalmol. 2013.

The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances.

Subscribe to our Blog